Posts by Robert S. Bader, M.D., Dermatologist
RESTYLANE AND PERLANE REBATE IS BACK: OFFER EXPIRES MARCH 31, 2012
Patients will receive a rebate of: $40 per cc of Restylane (minimum of 2-cc must be used in a single session to be eligible and there is a maximum of $360) $50 per cc of Perlane (no minimum and there is a maximum of $300) visit www.RestylaneUSA.com for details.
Read MoreCHILDREN USE MORE SUNSCREEN WHEN DISPENSED FROM A PUMP
A study published in the Archives of Dermatology found that children use the most sunscreen when dispensed from a pump, when compared with squeeze bottles and roll-on dispensers. Despite this finding, kids used half of the recommended amount even with the pump-dispenser.
Read MoreMELANOMA DRUG VEMURAFENIB MAY INCREASE RISK OF SQUAMOUS CELL CARCINOMA
According to a study published in the New England Journal of Medicine, Vemurafenib (Zelboraf) speeds the growth of squamous cell carcinoma. HealthDay explained that “roughly one-quarter of patients who take the medication develop a troublesome side effect: secondary skin cancers called squamous cell carcinomas.”
Read MoreXEOMIN, THE LATEST BOTOX ALTERNATIVE, HAS BEEN RELEASED.
Xeomin joins Dysport as an alternative to Botox. This product has been FDA-approved for the cosmetic treatment of frown lines. Unlike Dysport or Botox, this product contains pure toxin. It remains to be seen whether this product has any advantages over it’s predecessors.
Read MoreRESTYLANE FILLER FDA-APPROVED FOR USE IN THE LIPS
Although Restylane has been used safely in the lips in the United States since its release in 2004, it has now got the stamp of approval for this indication from the FDA. Restylane is now the only filler that is FDA approved for use in the lips.
Read MoreSHOULD MELANOMA EXCISIONS BE SO LARGE?
A study published in The Lancet by Dr. Peter Gillgren indicates that a 2-cm excision margin is safe and as sufficient as 4-cm margins for the removal of melanomas that are at least 2-mm thick. This study took place in Sweden and involved a total of 936 patients. This study indicates what has been believed for over a decade, that large…
Read MoreMALIGNANT MELANOMA IS THE MOST COMMON CANCER IN YOUNG CAUCASIAN WOMEN (AGES 25 TO 29)
According to the American Academy of Dermatology, Malignant Melanoma is the most common cancer in white women ages 25 to 29 years and the second most common form of cancer in women 15 to 30 years of age. Interestingly, these are the ages that many women will go the beach to get tan or use tanning beds. Despite…
Read MoreATHLETE’S FOOT – DON’T FORGET THE SHOES.
Athlete’s foot is a common problem that can result in itching and burning of the feet, in addition to dryness on the sole or maceration between the toes. In addition, this can lead to infection of the nails that can be difficult to eradicate. Often one treats the skin, but does not eradicate the possible…
Read MoreFREE ONLINE PSORIASIS TREATMENT TRACKING SYSTEM @ WWW.VECTICAL.COM
Galderma has launched the Treatment Tracker, a free online program that allows patients to have a private, online diary that will keep a record of their: signs and symptoms treatment history photos upcoming Dermatologist appointments In addition, this program provides a list of potential psoriasis triggers, which can be customized to help patients manage their…
Read MoreTHE NEW U.S. FDA GUIDELINES FOR RATING AND LABELING SUNSCREENS
Skin cancer is the most common cancer in the United Stated. One should use a broad-spectrum sunscreen that protects against both UVA and UVB rays. The SPF rating system only applies to the protection the sunscreen has against UVB and will still be used. Here are the changes in labeling: The highest SPF rating will now…
Read More